By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Thursday that its fourth-quarter revenues increased 8 percent, and 10 percent on a currency-neutral basis, led by a double-digit gain for its Clinical Diagnostics segment.

The Hercules, Calif.-based firm brought in total revenues of $533.7 million for the three-month period ended Dec. 31, compared to $495.1 million for Q4 2009. It easily beat analysts' consensus estimate of $514.5 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.